Home/Afro-Egyptian Journal of Infectious and Endemic Diseases/Article Record
Peer-Reviewed Article September 19, 2015

Dengue and Dengue Hemorrhagic Fever

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: Afro-Egyptian Journal of Infectious and Endemic Diseases
Publisher: Zagazig University, Faculty of Medicine, Endemic and Tropical Medicine Department • Egypt • 2090-7613 • 2090-7184
DOI: https://doi.org/10.21608/aeji.2015.17830

Abstract

Dengue is endemic in at least 100 countries in Asia, the Pacific, the Americas, Africa, and the Caribbean. The World Health Organization (WHO) estimates that 50 to 100 million infections occur yearly, including 500,000 dengue hemorrhagic fever (DHF) cases and 22,000 deaths, mostly among children. Both epidemic and endemic transmission of dengue viruses are maintained through a human-mosquito-human cycle involving mosquitoes of the genus Aedes (Stegomyia). Typical clinical manifestations of dengue range from self-limited dengue fever (DF) to dengue hemorrhagic fever with shock syndrome. Most dengue virus infections in adults are symptomatic. In contrast, most infections among children under age 15 years are asymptomatic or minimally symptomatic. Classic dengue fever is an acute febrile illness accompanied by malaise, headache, retro orbital pain, and marked muscle and joint pains, which evoked the term "break-bone fever". DHF is the most serious manifestation of dengue virus infection and can be associated with circulatory failure and shock. Plasma leakage is the most specific and life-threatening feature of DHF.

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

120
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.